InterCure Ltd. (NASDAQ:INCR) (TSX:INCR) (TASE: INCR), which is doing business as Canndoc, has signed a definitive agreement to acquire Cann Pharmaceutical Ltd., also known as Better.
Under the terms of the agreement, InterCure will acquire 100% of Better’s shares, which includes “Better’s” unique strains, cultivation site, intellectual property, and commercial operations in Israel as well it’s international activities.
